Less-VT (NCT03490201)

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study 

This clinical investigation is intended to demonstrate the safety and effectiveness of ventricular ablation therapy using the FlexAbility Sensor Enabled Ablation Catheter in patients with drug-refractory monomorphic ventricular tachycardia in whom ventricular tachycardia recurs despite antiarrhythmic drug therapy or when antiarrhythmic drugs are not tolerated or desired.

PI: Nilesh Mathuria, MD

SPONSOR: Abbott Medical Devices

ACTIVE ENROLLING  SIGN UP